| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $11.3M | -29.9% |
| Cost of Revenue | $6.7M | -33.0% |
| Gross Profit | $4.6M | -24.7% |
| R&D Expense | $2.9M | -34.5% |
| SG&A Expense | $7.2M | -17.4% |
| Operating Income | -$13.1M | +22.1% |
| Pre-tax Income | -$20.7M | -25.8% |
| Income Tax | -$9K | -105.6% |
| Net Income | -$20.7M | -24.5% |
| EPS (Basic) | -$40.43 | -1620.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $14.4M | +998.5% |
| Accounts Receivable | $2.5M | -34.9% |
| Current Assets | $18.2M | +216.6% |
| Total Assets | $21.9M | +86.7% |
| Current Liabilities | $4.2M | -60.0% |
| Total Liabilities | $4.3M | -62.4% |
| Stockholders' Equity | $17.5M | — |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.7M | +6.9% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | $916K | +423.7% |
| Financing Cash Flow | $22.8M | +319.3% |
| Free Cash Flow | -$10.7M | +7.1% |